Investment Firm
Overview
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
Jul 05, 2017
Series Unknown
Highlights
Location
Social
Participant Investors
3
Investor Name |
---|
Black Beret Life Sciences |
JDRF T1D Fund |
Medicxi |
Diasome Pharmaceuticals raised $30000000 on 2017-07-05 in Venture Round
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
Company Funding History
7
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Sep 08, 2022 | Venture Round - Diasome Pharmaceuticals | - | 16.7M | |
Jun 30, 2023 | Venture Round - Diasome Pharmaceuticals | - | 9.0M | |
Jul 05, 2017 | Venture Round - Diasome Pharmaceuticals | 4 | - | 30.0M |
Apr 13, 2009 | Debt Financing - Diasome Pharmaceuticals | - | 12.9M |
Recent Activity
There is no recent news or activity for this profile.